Spinal Muscular Dystrophy Market

1
(No Transcript)
2
Spinal Muscular Atrophy (SMA)
Spinal muscular atrophy is a genetic disease
affecting the part of the nervous system that
controls voluntary muscle movement. 
01
02
03
04
The majority of SMA prevalent population belongs
to SMA Type 2 and SMA Type 3.

• DelveInsight 2019 All rights reserved

3
Cases of SMA
The total prevalent population of Spinal Muscular
Atrophy in 7 major markets was 19,343 in 2017
while the total diagnosed prevalent population of
Spinal Muscular Atrophy in 7 major markets was
17,094 in 2017.

• DelveInsight 2019 All rights reserved

4
Market Outlook
The total prevalence of Spinal Muscular Atrophy
in the US is expected to increase at a CAGR of
0.77 for the study period of 2017-2028.
The diagnosed prevalent population of Spinal
Muscular Atrophy in 7MM is expected to increase
at a CAGR of 0.88 for the study period.
The market size of Spinal Muscular Atrophy in
seven major markets is expected to increase from
1,317 Million in 2017 at a CAGR of 10.42.

• DelveInsight 2019 All rights reserved

5
Emerging Therapies
(Companies)
(Drugs)
RELDESEMTIV

• DelveInsight 2019 All rights reserved

6
Report
SMA Report Insights
SMA Report Key Strengths
SMA Report Assessment

• DelveInsight 2019 All rights reserved

7
Complete Information
For complete information on
Spinal Muscular Atrophy - Market Insights,
Epidemiology and Market Forecast-2028 please
click the link below
CLICK HERE
OR
Write Us At 
info_at_delveinsight.com

• DelveInsight 2019 All rights reserved

8
About DelveInsight
1
2
3

• DelveInsight 2019 All rights reserved

9
Service Offerings by DelveInsight

• DelveInsight 2019 All rights reserved

10
Contact Us
info_at_delveinsight.com
91-11-4568 9769
www.delveinsight.com
blog/delveInsight/
twitter/delveInsight
LinkedIn/delveInsight

• DelveInsight 2019 All rights reserved

11
(No Transcript)